DIN 02444623 — STRENSIQ 40 MG
STRENSIQ is a solution of Asfotase alfa marketed by ALEXION PHARMA GMBH. The full Asfotase alfa monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02444623
- Brand name
- STRENSIQ
- Active ingredient
- Asfotase alfa
- Strength
- 40 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- ALEXION PHARMA GMBH
- Health Canada status
- MARKETED
- Drug class
- Enzyme replacement therapy (recombinant tissue-nonspecific alkaline phosphatase)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Asfotase alfa products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02444658 | STRENSIQ | 100 MG | SOLUTION | ALEXION PHARMA GMBH | MARKETED |
| 02444615 | STRENSIQ | 40 MG | SOLUTION | ALEXION PHARMA GMBH | MARKETED |
| 02444631 | STRENSIQ | 40 MG | SOLUTION | ALEXION PHARMA GMBH | MARKETED |